Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
02 2ALFRED E TIEFENBACHER GmbH & Co KG
03 2Ascent Innovative Medicines
04 2Aspire Lifesciences Pvt Ltd
05 2Eurofarma Laboratorios S.A.
06 1Jivita Health Care
07 1Noucor
08 2Precise Group
09 2YICHANG HUMANWELL PHARMACEUTICAL CO., LTD
10 2Blank
01 4Desvenlafaxine
02 3Desvenlafaxine Succinate
03 10desvenlafaxine
01 4Coated Tablet
02 3ER Tablet
03 2Extended Release Tablet
04 2Granules
05 2Prolonged Release tablet
06 1Sustain Release Pellet
07 1Sustained Release Tablet
08 2Tablet
01 7100MG
02 141.38%
03 850MG
04 150MG; 100MG
01 4Brazil
02 2China
03 2Germany
04 8India
05 1Spain
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 41.38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Packaging :
Regulatory Info :
Dosage : Sustain Release Pellet
Dosage Strength : 41.38%
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tabl...
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany